NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Poor Man -,

No one understands DC cell characteristics needed and ability to create them better than NWBO because they have been at it longer on the right track than anyone. Everyone, including regulators, are trying to catch up to understanding what they are doing and figure out a way to prepare for quality control based on that. The number of new hires with cell therapy quality control experience that FDA has been trying to get should tell you that a significant ramp up is in the works and a tissue agnostic classification for L and Direct might just have that kind of impact now. Best wishes.